Literature DB >> 22071139

Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis.

Maya Koren-Michowitz1, Aiko Sato-Otsubo, Arnon Nagler, Torsten Haferlach, Seishi Ogawa, H Phillip Koeffler.   

Abstract

Older patients with AML have a worse outcome compared to young patients. To study for potential contributors to their poor prognosis, we compared two NK-AML cohorts, young (< 60 years old) and old (≥ 60 years old), via high density SNP array analysis. Older patients had more genomic changes (1.83 ± 0.23 vs. 1.16 ± 0.2, p=0.037) and a trend for a higher number of copy number neutral loss of heterozygosity (0.5 ± 0.2 vs. 0.24 ± 0.08, p=0.088) compared to young patients. We speculate that complex genomic changes in NK-AML may be a sign of an increase in genomic instability and an indicator of a worse prognosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22071139      PMCID: PMC3288295          DOI: 10.1016/j.leukres.2011.10.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  15 in total

1.  Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.

Authors:  Brian Parkin; Harry Erba; Peter Ouillette; Diane Roulston; Anjali Purkayastha; Judith Karp; Moshe Talpaz; Lisa Kujawski; Sajid Shakhan; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Blood       Date:  2010-08-20       Impact factor: 22.113

Review 2.  The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.

Authors:  D Grimwade
Journal:  Best Pract Res Clin Haematol       Date:  2001-09       Impact factor: 3.020

3.  Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype.

Authors:  Tatiana Alessandra Gorletta; Patrizia Gasparini; Mario Milco D'Elios; Maurizio Trubia; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

Review 4.  Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Authors:  Krzysztof Mrózek; Guido Marcucci; Peter Paschka; Susan P Whitman; Clara D Bloomfield
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

5.  Age and acute myeloid leukemia.

Authors:  Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

6.  Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.

Authors:  Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria-Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

7.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

8.  Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.

Authors:  Go Yamamoto; Yasuhito Nannya; Motohiro Kato; Masashi Sanada; Ross L Levine; Norihiko Kawamata; Akira Hangaishi; Mineo Kurokawa; Shigeru Chiba; D Gary Gilliland; H Phillip Koeffler; Seishi Ogawa
Journal:  Am J Hum Genet       Date:  2007-06-05       Impact factor: 11.025

Review 9.  Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.

Authors:  Annahita Sallmyr; Jinshui Fan; Feyruz Virgilia Rassool
Journal:  Cancer Lett       Date:  2008-05-07       Impact factor: 8.679

10.  A method for accurate detection of genomic microdeletions using real-time quantitative PCR.

Authors:  Rosanna Weksberg; Simon Hughes; Laura Moldovan; Anne S Bassett; Eva W C Chow; Jeremy A Squire
Journal:  BMC Genomics       Date:  2005-12-13       Impact factor: 3.969

View more
  4 in total

Review 1.  The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60years.

Authors:  Sarah A Wall; Steven Devine; Sumithira Vasu
Journal:  Blood Rev       Date:  2017-07-15       Impact factor: 8.250

2.  Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.

Authors:  Soo-Jeong Kim; June-Won Cheong; Dae-Young Kim; Je-Hwan Lee; Kyoo-Hyung Lee; Yeo-Kyeoung Kim; Hyeong-Joon Kim; Ik-Chan Song; Deog-Yeon Jo; Jeong-Ok Lee; Soo-Mee Bang; Jinny Park; Jae Hoon Lee; Won-Sik Lee; Young-Don Joo; Chi Hoon Maeng; Hwi-Joong Yoon; Na-Ri Lee; Jae-Yong Kwak; Kyoung Ha Kim; Jong-Ho Won; Bo Ram Han; Dae Young Zang; Joon Ho Moon; Sang Kyun Sohn; Sung Hwa Bae; Hun Mo Ryoo; Sung-Yong Kim; Mark Hong Lee; Yoo Hong Min
Journal:  Int J Hematol       Date:  2014-07-05       Impact factor: 2.490

Review 3.  Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Authors:  Ilaria Iacobucci; Annalisa Lonetti; Cristina Papayannidis; Giovanni Martinelli
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

Review 4.  Bridging Strategies to Allogeneic Transplant for Older AML Patients.

Authors:  Judith Hecker; Isabella Miller; Katharina S Götze; Mareike Verbeek
Journal:  Cancers (Basel)       Date:  2018-07-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.